LIM kinase 1 increases tumor metastasis of human breast cancer cells via regulation of the urokinase-type plasminogen activator system

International Journal of Cancer

Volumn 118, Issue 11, 2006, Pages 2703-2710

  Bagheri Yarmand, Rozita ^a   Mazumdar, Abhijit ^a   Sahin, Aysegul A ^a   Kumar, Rakesh ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Angiogenesis; LIMK1; Metastasis; uPA; uPAR

Indexed keywords

ACTIN; COFILIN; LIM KINASE 1; LIM PROTEIN; MUTANT PROTEIN; PROTEIN KINASE; SERINE PROTEINASE; UNCLASSIFIED DRUG; UROKINASE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSKELETON; ENZYME REGULATION; EXTRACELLULAR MATRIX; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIVER METASTASIS; LUNG METASTASIS; METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; BREAST NEOPLASMS; CELL MOVEMENT; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MICE; MICE, NUDE; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROTEIN KINASES; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 33646376457     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21650     Document Type: Article

References (34)

1. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002;2:563-72.
2. Lauffenburger DA, Horwitz AF. Cell migration: a physically integrated molecular process. Cell 1996;84:359-69.
3. Mitchison TJ, Cramer LP. Actin-based cell motility and locomotion. Cell 1996;84:371-9.
4. Lawler S. Regulation of actin dynamics: the LIM kinase connection. Curr Biol 1999;9:800-2.
5. Okano I, Hiraoka J, Otera H, Nunoue K, Ohashi K, Iwashita S, Hirai M, Mizuno K. Identification and characterization of a novel family of serine/threonine kinases containing N-terminal two LIM motifs. J Biol Chem 1995;270:31321-30.
6. Bernard O, Ganiatsas S, Kannourakis G, Dringen R. Kiz-1, a protein with LIM zinc finger and kinase domains, is expressed mainly in neurons. Cell Growth Differ 1994;5:1159-71.
7. Cheng AK, Robertson EJ. The murine LIM-kinase gene (limk) encodes a novel serine threonine kinase expressed predominantly in tropoblast giant cells and in the developing nervous system. Mech Dev 1995;52:187-97.
8. Moon A, Drubin D. The ADF/cofilin proteins: stimulus-responsive modulators of actin dynamics. Mol Biol Cell 1995;6:1423-31.
9. Theriot JA. Accelerating on a treadmill: ADF/cofilin promotes rapid actin filament turnover in the dynamic cytoskeleton. J Cell Biol 1997;136:1165-8.
10. Lappalainen P, Drubin DG. Cofilin promotes rapid actin filament turn-over in vivo. Nature 1997;388:78-82.
11. Arber S, Barbayannis FA, Hanser H, Schneider C, Stanyon CA, Bernard O, Caroni P. Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. Nature 1998;393:805-9.
12. Yang N, Higuchi O, Ohashi K, Nagata K, Wada A, Kangawa K, Nishida E, Mizuno K. Cofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization. Nature 1998;393:809-12.
13. Davila M, Frost AR, Grizzle WE, Chakrabarti R. LIM kinase 1 is essential for the invasive growth of prostate epithelial cells. J Biol Chem 2003;278:36868-75.
14. Yoshioka K, Foletta V, Bernard O, Itoh K. A role of LIM kinase in cancer invasion. Proc Natl Acad Sci U S A 2003;100:7247-52.
15. Blasi F, Carmeliet P. uPAR: a versatile signaling orchestrator. Nat Rev Mol Cell Biol 2002;3:932-42.
16. Ossowski L, Aguirre-Ghiso JA. Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth. Curr Opin Cell Biol 2000;12:613-20.
17. Andreasen PA, Kjoller L, Christensen L, Duffy MJ. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 1997;72:1-22.
18. Min HY, Doyle LV, Vitt CR, Zandonella CL, Stratton-Thomas JR, Shuman MA, Rosenberg S. Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice. Cancer Res 1996;56:2428-33.
19. Crowley CW, Cohen RL, Lucas BK, Liu G, Shuman MA, Levinson AD. Prevention of metastasis by inhibition of Urokinase receptor. Proc Natl Acad Sci U S A 1993;90:5021-5.
20. Stephens RW, Nielsen HJ, Christensen IJ, Thorlacius-Usssing O, Sorensen S, Dano K, Brunner N. Plasma urokinase receptor levels in patients with colorectal cancer: relationship to prognosis. J Natl Cancer Inst 1999;91:869-74.
21. Brunner N, Nielsen HJ, Hamers M, Christensen IJ, Thorlacius-Ussing, Stephens RW. The urokinase plasminogen activator receptor in blood from healthy individuals and patients with cancer. APMIS 1999;107:160-7.
22. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249-57.
23. Proschel C, Blouin MJ, Gutowski NJ, Ludwig R, Nobel M. LIMK1 is predominantly expressed in neural tissues and phosphorylates serine, threonine and tyrosine residues in vitro. Oncogene 1995;11:1271-81.
24. Edwards DC, Sanders LC, Bokoch GM, Gill GN. Activation of LIM-kinase by PAK1 couples Rac/Cdc42 GTPase signaling to actin cytoskeletal dynamics. Nat Cell Biol 1999;1:253-59.
25. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 1987;47:936-42.
26. Allgayer H, Wang H, Gallick GE, Crabtree A, Mazer A, Jones T, Kraker AJ, Boyd D. Transcriptional induction of the urokinase receptor gene by a constitutively active Src. Requirement of an upstream motif (-152/-135) bound with Sp1. J Biol Chem 1999;274:18428-37.
27. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
28. Mohanam S, Sawaya R, McCutcheon I, Ali-Osman F, Boyd D, Rao JS. Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody. Cancer Res 1993;53:4143-7.
29. Kjoller L, Hall A. Rac mediates cytoskeletal rearrangements and increased cell motility induced by urokinase-type plasminogen activator receptor binding to vitronectin. J Cell Biol 2001;152:1145-57.
30. Sumi T, Matsumoto K, Nakamura T. Mitosis-dependent phosphorylation and activation of LIM-kinase 1. Biochem Biophys Res Commun 2002;290:1315-20.
31. Amano T, Kaji N, Ohashi K, Mizuno K. Mitosis-specific activation of LIM motif-containing protein kinase and roles of cofilin phosphorylation and dephosphorylation in mitosis. J Biol Chem 2002;277:22093-102.
32. Mazar AP, Henkin J, Goldfarb RH. The urokinase plasminogen activator system in cancer: implications for tumor angiogenesis and metastasis. Angiogenesis 1999;3:15-32.
33. Duggan C, Maguire T, McDermott E, O'Higgins N, Fennelly JJ, Duffy MJ. Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer. Int J Cancer 1995;61:597-600.
34. Grondahl-Hansen J, Peters HA, Van Putten WLJ, Look MP, Pappot H, Ronne E, Dano K, Klijn JGH, Brunner N, Foekens JA. Prognostic significance of the receptor for urokinase plasminogen activator in breast cancer. Clin Cancer Res 1995;1:1079-87.